Fundraising FoxEpitome Therapeutics
Vienna, AT · 1 known investors
Find your way into Epitome Therapeutics
Sign up to see every warm intro you have to Epitome Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Epitome Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, an epigenome editing platform that controls gene expression without changing the DNA sequence. It targets diseases driven by dysregulated gene activity, including rare and metabolic disorders.
Investors · 1
Frequently asked questions
- What does Epitome Therapeutics do?
- Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, an epigenome editing platform that controls gene expression without changing the DNA sequence. It targets diseases driven by dysregulated gene activity, including rare and metabolic disorders.
- Who are Epitome Therapeutics's investors?
- Epitome Therapeutics's investors include xista science ventures.
- Where is Epitome Therapeutics headquartered?
- Epitome Therapeutics is headquartered in Vienna, AT.